vs

Side-by-side financial comparison of AMERISERV FINANCIAL INC (ASRV) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

cbdMD, Inc. is the larger business by last-quarter revenue ($5.0M vs $3.9M, roughly 1.3× AMERISERV FINANCIAL INC). AMERISERV FINANCIAL INC runs the higher net margin — 36.9% vs -5.6%, a 42.6% gap on every dollar of revenue. On growth, AMERISERV FINANCIAL INC posted the faster year-over-year revenue change (2.4% vs -1.9%). Over the past eight quarters, cbdMD, Inc.'s revenue compounded faster (7.1% CAGR vs -46.6%).

Ameriserv Financial Inc. is a Pennsylvania-headquartered regional financial services holding company. It provides retail and commercial banking products including deposit accounts, loan products and wealth management solutions, serving individual consumers and SMEs across its local operating markets in the United States.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

ASRV vs YCBD — Head-to-Head

Bigger by revenue
YCBD
YCBD
1.3× larger
YCBD
$5.0M
$3.9M
ASRV
Growing faster (revenue YoY)
ASRV
ASRV
+4.3% gap
ASRV
2.4%
-1.9%
YCBD
Higher net margin
ASRV
ASRV
42.6% more per $
ASRV
36.9%
-5.6%
YCBD
Faster 2-yr revenue CAGR
YCBD
YCBD
Annualised
YCBD
7.1%
-46.6%
ASRV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASRV
ASRV
YCBD
YCBD
Revenue
$3.9M
$5.0M
Net Profit
$1.4M
$-283.1K
Gross Margin
59.8%
Operating Margin
43.0%
-5.7%
Net Margin
36.9%
-5.6%
Revenue YoY
2.4%
-1.9%
Net Profit YoY
62.2%
-1975.7%
EPS (diluted)
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASRV
ASRV
YCBD
YCBD
Q4 25
$3.9M
$5.0M
Q3 25
$15.4M
$4.7M
Q2 25
$14.5M
$4.6M
Q1 25
$14.1M
$4.7M
Q4 24
$3.8M
$5.1M
Q3 24
$13.1M
$4.6M
Q2 24
$13.2M
$5.2M
Q1 24
$13.7M
$4.4M
Net Profit
ASRV
ASRV
YCBD
YCBD
Q4 25
$1.4M
$-283.1K
Q3 25
$2.5M
$-680.0K
Q2 25
$-282.0K
$-895.3K
Q1 25
$1.9M
$-480.8K
Q4 24
$889.0K
$15.1K
Q3 24
$1.2M
$-152.8K
Q2 24
$-375.0K
$459.7K
Q1 24
$1.9M
$-3.0M
Gross Margin
ASRV
ASRV
YCBD
YCBD
Q4 25
59.8%
Q3 25
58.8%
Q2 25
61.5%
Q1 25
62.3%
Q4 24
66.5%
Q3 24
53.9%
Q2 24
65.8%
Q1 24
59.0%
Operating Margin
ASRV
ASRV
YCBD
YCBD
Q4 25
43.0%
-5.7%
Q3 25
20.0%
-14.5%
Q2 25
-2.4%
-19.6%
Q1 25
17.0%
-10.2%
Q4 24
28.2%
-1.7%
Q3 24
10.8%
-6.9%
Q2 24
-3.7%
-7.4%
Q1 24
17.4%
-35.4%
Net Margin
ASRV
ASRV
YCBD
YCBD
Q4 25
36.9%
-5.6%
Q3 25
16.5%
-14.4%
Q2 25
-1.9%
-19.4%
Q1 25
13.6%
-10.1%
Q4 24
23.3%
0.3%
Q3 24
9.0%
-3.4%
Q2 24
-2.8%
8.9%
Q1 24
13.9%
-68.8%
EPS (diluted)
ASRV
ASRV
YCBD
YCBD
Q4 25
$0.09
Q3 25
$0.15
Q2 25
$-0.02
Q1 25
$0.12
Q4 24
$0.05
Q3 24
$0.07
Q2 24
$-0.02
$-0.15
Q1 24
$0.11
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASRV
ASRV
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$3.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$119.3M
$9.0M
Total Assets
$1.5B
$11.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASRV
ASRV
YCBD
YCBD
Q4 25
$3.4M
Q3 25
$2.3M
Q2 25
$1.1M
Q1 25
$1.8M
Q4 24
$2.0M
Q3 24
$2.5M
Q2 24
$2.4M
Q1 24
$2.1M
Stockholders' Equity
ASRV
ASRV
YCBD
YCBD
Q4 25
$119.3M
$9.0M
Q3 25
$114.6M
$7.2M
Q2 25
$110.9M
$6.1M
Q1 25
$110.8M
$665.8K
Q4 24
$107.2M
$1.8M
Q3 24
$108.2M
$2.0M
Q2 24
$103.7M
$3.0M
Q1 24
$103.9M
$3.1M
Total Assets
ASRV
ASRV
YCBD
YCBD
Q4 25
$1.5B
$11.8M
Q3 25
$1.5B
$10.4M
Q2 25
$1.4B
$9.9M
Q1 25
$1.4B
$10.9M
Q4 24
$1.4B
$11.5M
Q3 24
$1.4B
$10.6M
Q2 24
$1.4B
$13.8M
Q1 24
$1.4B
$14.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASRV
ASRV
YCBD
YCBD
Operating Cash FlowLast quarter
$3.2M
$-812.5K
Free Cash FlowOCF − Capex
$-977.3K
FCF MarginFCF / Revenue
-19.5%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
2.21×
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASRV
ASRV
YCBD
YCBD
Q4 25
$3.2M
$-812.5K
Q3 25
$1.4M
$-240.7K
Q2 25
$-62.0K
$-704.2K
Q1 25
$599.0K
$-189.5K
Q4 24
$2.7M
$-317.9K
Q3 24
$-235.0K
$167.4K
Q2 24
$1.7M
$289.8K
Q1 24
$-2.2M
$-704.1K
Free Cash Flow
ASRV
ASRV
YCBD
YCBD
Q4 25
$-977.3K
Q3 25
$-243.6K
Q2 25
$-705.7K
Q1 25
$-205.0K
Q4 24
$-482.3K
Q3 24
$157.4K
Q2 24
Q1 24
$-708.7K
FCF Margin
ASRV
ASRV
YCBD
YCBD
Q4 25
-19.5%
Q3 25
-5.2%
Q2 25
-15.3%
Q1 25
-4.3%
Q4 24
-9.4%
Q3 24
3.5%
Q2 24
Q1 24
-16.2%
Capex Intensity
ASRV
ASRV
YCBD
YCBD
Q4 25
3.3%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.3%
Q4 24
3.2%
Q3 24
0.2%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
ASRV
ASRV
YCBD
YCBD
Q4 25
2.21×
Q3 25
0.55×
Q2 25
Q1 25
0.31×
Q4 24
3.02×
-21.06×
Q3 24
-0.20×
Q2 24
0.63×
Q1 24
-1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASRV
ASRV

Asset Management1$3.1M79%
Other$838.0K21%

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons